.
ISSN 2063-5346
-
BIOCHEMISTRY OF FASTING – A REVIEW ON METABOLIC SWITCH AND AUTOPHAGY.
Volume - 13 | Issue-1
-
ONE-POT ENVIRONMENT FRIENDLY SYNTHESIS OF IMINE DERIVATIVE OF FURFURAL AND ASSESSMENT OF ITS ANTIOXIDANT AND ANTIBACTERIAL POTENTIAL
Volume - 13 | Issue-1
-
MODELING AND ANALYSIS OF MEDIA INFLUENCE OF INFORMATION DIFFUSION ON THE SPREAD OF CORONA VIRUS PANDEMIC DISEASE (COVID-19)
Volume - 13 | Issue-1
-
INCIDENCE OF HISTOPATHOLOGICAL FINDINGS IN APPENDECTOMY SPECIMENS IN A TERTIARY CARE HOSPITAL IN TWO-YEAR TIME
Volume - 13 | Issue-1
-
SEVERITY OF URINARY TRACT INFECTION SYMPTOMS AND THE ANTIBIOTIC RESISTANCE IN A TERTIARY CARE CENTRE IN PAKISTAN
Volume - 13 | Issue-1
EFFECT OF EMPAGLIFLOZIN VS PIOGLITAZONE VS METFORMIN WITH URSODEOXYCHOLIC ACID AND VITAMIN E IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS IN EGYPTIAN PATIENTS WITHOUT DM
Main Article Content
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of chronic liver disease and is now among the top causes of cirrhosis, hepatocellular carcinoma (HCC). No pharmacotherapies are approved for NAFLD in non-diabetic patients. Aim: We aimed to compare empagliflozin to pioglitazone and a combination of metformin, Ursodeoxycholic acid, and vitamin E (MET+UDCA+VitE) in nondiabetic patients with NAFLD, and to assess the impact of these therapies on autotaxin and cytokeratin 18.
Article Details
